We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Stemcells, Inc. Relocates Corporate Headquarters and U.S. Research Labs

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Stemcells, Inc. Relocates Corporate Headquarters and U.S. Research Labs"

First Name*
Last Name*
Email Address*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:

StemCells, Inc. has announced that it has relocated its corporate headquarters and U.S.-based research and development operations to 7707 Gateway Blvd, Newark, CA 94560, USA.

The new facilities comprise newly constructed, custom designed laboratory and office space, and will house the majority of the Company’s U.S. workforce. The Company’s new main telephone number is (510) 456-4000.

“This is a ‘win win’ situation for employees and shareholders alike,” said Martin McGlynn, President and CEO of StemCells.

McGlynn continued, “Not only are we providing our scientists with modern, state of the art, R&D facilities designed to foster their ground breaking work, but by moving to the Pacific Research Center in Newark, we are significantly reducing the Company’s annual facility lease and operating expenses.”

StemCells’ other facilities in Cambridge, U.K., where the Company researches, develops and manufactures its SC Proven® line of media and reagent products, and in Mountain View, California, are not affected by this move.